10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,773,659 | +187.8% | 455,119 | +289.6% | 0.05% | +130.0% |
| Q2 2023 | $6,522,559 | +1504.0% | 116,808 | +1502.5% | 0.02% | +900.0% |
| Q1 2023 | $406,653 | +17.6% | 7,289 | -23.2% | 0.00% | +100.0% |
| Q4 2022 | $345,852 | -71.8% | 9,491 | -78.0% | 0.00% | -83.3% |
| Q3 2022 | $1,226,000 | +97.1% | 43,047 | +931.1% | 0.01% | +200.0% |
| Q4 2021 | $622,000 | -90.2% | 4,175 | -90.7% | 0.00% | -95.7% |
| Q4 2020 | $6,331,000 | +2060.8% | 44,709 | +1802.5% | 0.05% | +1075.0% |
| Q3 2020 | $293,000 | -0.3% | 2,350 | -28.7% | 0.00% | -20.0% |
| Q2 2020 | $294,000 | – | 3,294 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |